• Go to navigation
  • Go to content
Patient Health International

You are here

  • Home
  • AstraZeneca medicines
  • Zomig® (zolmitriptan)

Astrazeneca global websites

  • AstraZeneca Websites

Main navigation

  • Home
  • News & feature articles
  • Body map
  • List of health conditions
  • Migraine
  • Interactive area
  • Interactive learning
  • About medicines
  • AstraZeneca medicines
  • About clinical trials
  • Glossary
  • Links
  • Sitemap

Zomig® (zolmitriptan)

Alternative brand (trade) names: Zomigon and AscoTop

What is Zomig® ?

This medicine contains zolmitriptan, which is one of the more recent medications designed specifically for migraine. This family of medications, to which zolmitriptan belongs, are often referred to as ‘triptans’.

What is Zomig® used for?

Zomig is used to treat migraine.

How does Zomig® work ?

  • Several changes in the brain that are involved in the development of migraine attacks have been identified.

  • Migraines are believed to result from nerve activity and swelling of the blood vessels in the brain.

  • Zomig acts at several of these sites that are thought to be involved in producing migraine symptoms, such as the blood vessels in the brain and the nerves involved in the signalling of the headache.

How is Zomig® given ?

Zomig is supplied as standard tablets for swallowing or as fast-melt tablets which dissolve quickly on the tongue and therefore can be taken without drinking liquid.

Zomig is taken as soon as possible after the onset of the migraine attack.

It is also supplied as a nasal spray in some countries.

Country specific information

To consult your local information.

Any medical information on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. Read more important information.

Back to search

  • Advanced search

Quick links

  • Investor information
  • Press information
  • AstraZeneca US

Page tools

  • Print
  • Bookmark this page

Related links

  • Other countries

List of conditions

AstraZeneca medicines

AstraZeneca International

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2009